Syndrome of the Month: An Update on Smith‐Kingsmore Syndrome: Characterization of Developmental Milestones and a Review of the Literature
American Journal of Medical Genetics Part A · 2026-04 · 200 (4) · 800-806
DOI: 10.1002/ajmg.a.64307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 11.11.2025. Verfasst von Carolyn R Raski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics & Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Megalencephaly. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Smith‐Kingsmore syndrome (SKS) is a rare autosomal dominant condition characterized by neurodevelopmental differences, macrocephaly/megalencephaly, describable facial features, sleep–wake abnormalities, hyperphagia, and overgrowth. SKS is caused by pathogenic gain‐of‐function variants in MTOR which lead to hyperactivation of the mTOR pathway. In this review, we discuss the history, epidemiology, molecular basis, clinical features, and management considerations for Smith‐Kingsmore syndrome. In addition, we provide insight on early developmental milestones through a report on 14 individuals with a confirmed diagnosis of SKS. Among these individuals, 8/12 (67%) achieved crawling at an average age of 23 months, 9/14 (64%) achieved walking with an average age of 32 months, 5/9 (56%) achieved a pincer grasp at an average age of 23 months, 8/12 (67%) achieved the ability to use a device or utensil with an average age of 3.4 years, 10/13 (77%) achieved babbling at an average age of 20 months, 8/14 (57%) achieved their first word at an average age of 34 months, and 4/14 (29%) achieved the use of short phrases at an average age of 4.6 years. This review highlights advances in characterizing the natural history of SKS since it was first described 12 years ago and the need for additional research to inform genotype–phenotype correlations and targeted therapies to support individuals with SKS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics & Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: Carolyn R Raski, Carlos E Prada
Zitieren
APA
Raski, C. R., & Prada, C. E. (2026). Syndrome of the Month: An Update on Smith‐Kingsmore Syndrome: Characterization of Developmental Milestones and a Review of the Literature. American Journal of Medical Genetics Part A, 200(4), 800-806. https://doi.org/10.1002/ajmg.a.64307
Vancouver
Raski CR, Prada CE. Syndrome of the Month: An Update on Smith‐Kingsmore Syndrome: Characterization of Developmental Milestones and a Review of the Literature. American Journal of Medical Genetics Part A. 2026;200(4):800-806. doi:10.1002/ajmg.a.64307
BibTeX
@article{Raski2026,
author = {Raski, Carolyn R and Prada, Carlos E},
title = {Syndrome of the Month: An Update on Smith‐Kingsmore Syndrome: Characterization of Developmental Milestones and a Review of the Literature},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {4},
pages = {800--806},
doi = {10.1002/ajmg.a.64307}
}
EUVIMED